Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G T Wurz

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Anti-Cancer Drugs|March 24, 1998
Intratumoral toremifene therapy and tissue distribution in the baboonG T Wurz, J U Mäenpää, G B Hubbard, et al.
Breast Cancer Research and Treatment|January 1, 1992
Monitoring the chemosensitizing effects of toremifene with flow cytometry in estrogen receptor negative multidrug resistant human breast cancer cellsW J Baker, V J Wiebe, S K Koester, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Tissue distribution of transdermal toremifeneL Soe, G T Wurz, J U Mäenpää, et al.
Oncology Research|January 1, 1993
Toremifene enhances cell cycle block and growth inhibition by vinblastine in multidrug resistant human breast cancer cellsW J Baker, J U Maenpaa, G T Wurz, et al.
Breast Cancer Research and Treatment|January 1, 1994
Flow cytometry: potential utility in monitoring drug effects in breast cancerS K Koester, J U Maenpaa, V J Wiebe, et al.
Oncology Research|January 1, 1993
A breast cancer clone selected by tamoxifen has increased growth rate and reduced sensitivity to doxorubicinJ U Maenpaa, G T Wurz, W J Baker, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Prolonged tamoxifen exposure selects a breast cancer cell clone that is stable in vitro and in vivoP E Sipila, V J Wiebe, G B Hubbard, et al.
Cancer Chemotherapy and Pharmacology|October 27, 1998
High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinicallyP N Lara, D R Gandara, G T Wurz, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Anti-Cancer Drugs|March 24, 1998
Intratumoral toremifene therapy and tissue distribution in the baboonG T Wurz, J U Mäenpää, G B Hubbard, et al.
Breast Cancer Research and Treatment|January 1, 1992
Monitoring the chemosensitizing effects of toremifene with flow cytometry in estrogen receptor negative multidrug resistant human breast cancer cellsW J Baker, V J Wiebe, S K Koester, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Tissue distribution of transdermal toremifeneL Soe, G T Wurz, J U Mäenpää, et al.
Oncology Research|January 1, 1993
Toremifene enhances cell cycle block and growth inhibition by vinblastine in multidrug resistant human breast cancer cellsW J Baker, J U Maenpaa, G T Wurz, et al.
Breast Cancer Research and Treatment|January 1, 1994
Flow cytometry: potential utility in monitoring drug effects in breast cancerS K Koester, J U Maenpaa, V J Wiebe, et al.
Oncology Research|January 1, 1993
A breast cancer clone selected by tamoxifen has increased growth rate and reduced sensitivity to doxorubicinJ U Maenpaa, G T Wurz, W J Baker, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Prolonged tamoxifen exposure selects a breast cancer cell clone that is stable in vitro and in vivoP E Sipila, V J Wiebe, G B Hubbard, et al.
Cancer Chemotherapy and Pharmacology|October 27, 1998
High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinicallyP N Lara, D R Gandara, G T Wurz, et al.
Pageof 2